Furthermore, by using a genetically engineered mouse model of lung adenocarcinoma by ablating Smarca4 in the lung epithelium, Deribe et al. demonstrated that Smarca4, as a bona fide tumor suppressor, cooperates with p53 loss and Kras activation through enhanced oxygen consumption and increased respiratory capacity. This evidence concerns the gene SMARCA4 and lung adenocarcinoma.